KDELR2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.7147999686884E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.64540000000291E-06 |
Normal-vs-Stage2 |
6.876100E-03 |
Normal-vs-Stage3 |
8.36440000000493E-05 |
Normal-vs-Stage4 |
8.19130000051516E-07 |
Stage1-vs-Stage2 |
3.115000E-01 |
Stage1-vs-Stage3 |
1.600220E-01 |
Stage1-vs-Stage4 |
1.935560E-03 |
Stage2-vs-Stage3 |
9.122000E-01 |
Stage2-vs-Stage4 |
1.715410E-01 |
Stage3-vs-Stage4 |
5.804500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.76759956566275E-10 |
Normal-vs-AfricanAmerican |
3.498200E-01 |
Normal-vs-Asian |
9.786100E-02 |
Caucasian-vs-AfricanAmerican |
1.7423000000516E-06 |
Caucasian-vs-Asian |
8.417600E-01 |
AfricanAmerican-vs-Asian |
1.506600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.39500000440052E-08 |
Normal-vs-Female |
2.89689999988241E-07 |
Male-vs-Female |
3.034400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.157600E-02 |
Normal-vs-Age(41-60Yrs) |
2.86400000049092E-07 |
Normal-vs-Age(61-80Yrs) |
5.81439999480793E-08 |
Normal-vs-Age(81-100Yrs) |
1.128760E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.577400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.621200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.155800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.746400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.415600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.920600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.957600E-01 |
Normal-vs-Grade 2 |
1.46530000000311E-06 |
Normal-vs-Grade 3 |
1.07810000038455E-07 |
Normal-vs-Grade 4 |
1.177540E-04 |
Grade 1-vs-Grade 2 |
2.560600E-01 |
Grade 1-vs-Grade 3 |
1.741240E-01 |
Grade 1-vs-Grade 4 |
1.166020E-02 |
Grade 2-vs-Grade 3 |
4.344000E-01 |
Grade 2-vs-Grade 4 |
5.565900E-02 |
Grade 3-vs-Grade 4 |
1.192810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.64323999999327E-05 |
Normal-vs-ccB subtype |
6.97499999979811E-07 |
ccA subtype-vs-ccB subtype |
5.604000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.50219999667445E-08 |
Normal-vs-N1 |
1.601890E-02 |
N0-vs-N1 |
2.957200E-01 |
|
|